Verastem Oncology (VSTM) Misses Q3 EPS by 54c

Verastem Oncology (NASDAQ: VSTM) reported Q3 EPS of ($0.54). Revenue for the quarter came in at $11.24 million.

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• SpaceX (SPCX) call put ratio 1.5 calls to 1 put as share price up 1.4%
• Jefferies: US equity ETF inflows jump to $27.8B on strong demand